Professional Documents
Culture Documents
Critical Appraisal
Name
Institution
CRITICAL APPRAISAL 2
Critical Appraisal
Introduction
Diabetes, a worldwide pandemic, continues to present huge health burdens for most
countries (Albright et al., 2000). Diabetes is considered a major risk factor for cardiovascular
disease development. In the United States alone, over 10 million diagnosed and 5 million
undiagnosed diabetes cases have been estimated in the general population (Albright et al., 2000).
However, a large portion of this disease burden falls upon the older adults and minority
populations (Castaneda et al., 2002). In particular, aging, coupled with unbalanced diets and
physical inactivity are some factors indicated to exacerbate the problem and/or induce insulin
sensitivity reduction. Globally, appropriate care of diabetes is largely essential at the primary
care, where individuals with type 2 diabetes are treated, and the best practice for disease
management is vital for success. The rise in the prevalence of type 2 diabetes, with associated
complications have called upon researchers (Albright et al., 2000; Castaneda et al., 2002; Conn
et al., 2007; Estacio et al., 1998; Michishita, Shono, Kasahara, & Tsuruta, 2008) to increasingly
investigate therapeutic measures proposed to enhance quality of life and improve health
outcomes.
well as pharmacological advances in this area, diabetic adults often fail to reach the required
metabolic control levels, and this is found to be correlated with increased risks of medical
problems associated with type 2 diabetes mellitus (Conn et al., 2007). The great variety of T2D
complications and the limited time required to solve these problems make it difficult for nurses
to personalize care for patients, considering individual barriers and needs. It is even more
difficult when one has to choose from the various and increasing number of new standardized
CRITICAL APPRAISAL 3
medications which may be beneficial, but also pose detrimental effects and risks. This problem
area of study is important to enhance evidence-based practice in nursing as it calls for non-
The present analysis is, therefore, conducted to integrate, review and synthesize research
Aside from type 2 diabetes, a chronic disease proved to be among the leading causes of
mortality and morbidity in the adult population worldwide, other concepts studied in literature
are therapeutic measures likely to improve the disease outcomes (Albright et al., 2000;
Castaneda et al., 2002; Conn et al., 2007). In this regard, exercise, described as the physical
activity required to lower microvascular and macrovascular complications specific for diabetes is
the emerging theme. Glycemic and/or metabolic control are determined by literature as the
changes and outcomes in glucose tolerance, which show the role of physical activity on
metabolic reactions in individuals with type 2 diabetes (Albright et al., 2000; Castaneda et al.,
2002; Conn et al., 2007; Estacio et al., 1998). Maximal oxygen consumption is also a concept
studied to reflect individual’s oxygen endurance capacity following prolonged exercise. The
current scholarly works have explored the impact of behavior-change interventions on type 2
diabetes control and related risks. The PICOT question is: In adults with type 2 diabetes, does the
use of exercise programs change the risk of cardiovascular disease when compared to the use of
Major Concepts/Themes
The emerging concepts in the 5 studies include the effect of exercise on type 2 diabetes
with regards to metabolic and glycemic control and/or oxygen consumption levels of individuals
with T2D. From the articles, there is accumulating findings that cardiovascular disease is a
CRITICAL APPRAISAL 4
resulting effect and a leading cause of mortality and morbidity in diabetic patients, but regular
moderate and high-intensity exercises are effective in T2D management. These physical
activities are associated with significantly improved glycemic and metabolic control, but such
rationale is that individuals with greater diabetic complications levels often have lower peak
oxygen consumption (Estacio et al., 1998), which affects exercise capacity. Nonetheless, acute
physical activity bouts can favorably change insulin resistance and abnormal blood glucose.
What was found similar in the studies is that frequent physical activities are beneficial in
the management of type 2 diabetes; appropriate physical activities enhance glycemic control and
increase insulin sensitivity. However, exercise capacity of the diabetic individual is important
(Estacio et al., 1998). The diminished exercise performance due to diabetic macrovascular
complications has negative implications for the ability of T2D individual to perform normal
activities, which may augment cardiac morbidity and mortality risks. In line with these findings,
Castaneda et al. (2002) demonstrated that resistance training significantly improved glycemic
and metabolic control, increased fat-free mass, reduced systolic blood pressure and abdominal
adiposity, and largely reduced the diabetes medication requirements. Therefore, subjects
undergoing resistance training are more likely to reduce many of T2D-related abnormalities
associated with the metabolic syndrome, including glucose intolerance, hypertension, and
hypertriglyceridemia. Similarly, other researchers (Michishita et al., 2008; Albright et al., 2000)
have found regular physical activity to have glucose-lowering effects and promote insulin
suggest better beta cell functioning after exercise therapy. Most importantly, all studies showed
an adverse effect of less-favorable glycemic status on mortality; increased fitness was shown to
CRITICAL APPRAISAL 5
promote glycemic control and metabolic outcomes (Conn et al., 2007), and reduce mortality risks
However, there were mixed findings in literature on how exercise would be an effective
modality in the management of type 2 diabetes, especially following diagnosis; hence the
association between the capacity to exercise and cardiovascular disease. Some authors (Albright
et al., 2000; Estacio et al., 1998) pointed out that certain microvascular and macrovascular
complications associated with T2D impair exercise capacity. The rationale is that those with type
2 diabetes can adapt less to physical training as they have low maximal oxygen uptake (Estacio
et al., 1998), yet modest increases in maximum oxygen consumption is essential in major
reductions in cardiovascular risks and mortality rates (Albright et al., 2000). Thus, the findings in
correlation between microvascular complications and exercise capacity (Estacio et al., 1998).
resistance training to be effective in improving glycemic control and reducing defects associated
with metabolic syndrome, Michishita et al. (2007) found the insulinogenic index in T2D patients
to have improved even after a low intensity exercise therapy. Other researchers identified the
combination of exercise and medical nutrition therapy as essential for the initial T2D treatment
to the extent even when drug therapy is required, such measures of weight loss/maintenance are
necessary for maintaining drug therapy efficacy (Albright et al., 2000). As indicated by Albright
et al. (200), while a low-intensity level exercise is adequate to aid metabolic changes, in some
patients it may fail to meet the required minimum threshold of exercise capacity for improving
cardiorespiratory endurance.
CRITICAL APPRAISAL 6
Critique of Research
The current studies, collectively, were designed to investigate diverse interventions for
Overall, as far as cardiac benefits are concerned, the data from these studies support the efficacy
appropriate for some populations with diabetic complications (Albright et al., 2000; Estacio et
al., 1998), the most promising of the current studies, however, is the potential well-being and
health gains of exercise therapy as outlined in the research. Most of the studies (Castaneda et al.,
2002; Conn et al., 2007; Estacio et al., 1998) incorporated controlled experiments to test
variations in the components and delivery of interventions. Such studies advance our
understanding of appropriate strategies for assessing and enhancing cardiac functioning in adults
However, few limitations exist in the current studies. Some, by design, control subjects
would receive standard care only, thereby lacking the same contact period as exercisers
(Castaneda et al., 2002). These researchers also ignored the observed chest pains of participants
during training, yet this underscores the importance of proper medical screening, prescription of
questions regarding the feasibility of employing exercise as the treatment for type 2 diabetes
present a number of potential pitfalls in the current type of studies. The 5 studies synthesized
and/or used a small/large number of male/female subjects of the total samples used, posing
unclear cardiovascular outcomes on whether women or men improve their behaviors less than
their counterparts. On one hand, the 5 studies benefit from a cohort of motivated subjects, who
CRITICAL APPRAISAL 7
are particularly interested in their health and will most likely engage in follow-up. However, in
the real world, individuals with diabetes may lack the motivation, and if the non-
pharmacological intervention is interrupted, efficacy results from exercise programs are difficult
to achieve. In this regard, the current studies suffer from verifiability issues due to limitations
emanating from lack of tools to assess adherence to the interventions, reproducibility, and
fidelity.
With regards to the evaluation criteria of the 5 studies, it is important to note that the
problem, purpose, question and/or hypothesis development of the current studies have been
identified. These studies (Castaneda et al., 2002; Conn et al., 2007; Estacio et al., 1998) have
clearly stated their purposes, problem, question and/or hypothesis development, and are
congruent with the information articulated in the literature or references used. However, some
descriptive studies (Albright et al., 2000) have not specifically identified these items; some have
basically referred to them in the analysis (Michishita et al., 2008). The sample sizes used in these
studies (if any) are adequate to produce generalizability of results and reduce the threat of
sampling errors. The target populations have been clearly identified; the samples selected, and/or
In this research, the concept of interest is whether exercise can change the risk of
cardiovascular disease in patients with T2D when compared to the use of standard care within six
months. From the research findings, there is enough evidence to show that exercise is an adjunct
to standard care in individuals with type 2 diabetes (Castaneda et al., 2002), and is more effective
than pharmacological therapies as it can change the risk of cardiovascular disease in this
population. In line with this evidence, these studies exploring the correlation between exercise
CRITICAL APPRAISAL 8
and T2D have revealed resistance training to be a potential modality for muscle strength and
endurance, improved body composition and flexibility (Albright et al., 2000), increased insulin
sensitivity and glucose tolerance (Castaneda et al., 2002; Michishita et al., 2008), while
Why it would be emphasized that these studies focus on and support the fact that
exercise, compared to standard care, change the risk of cardiovascular disease, is that most
researchers incorporated quantified mechanisms comparing treatment and control groups. They
either focused on interventions that would only emphasize exercise therapy or those targeting
multiple health behaviors. These diverse studies (Albright et al., 2000; Castaneda et al., 2002;
Conn et al., 2007; Estacio et al., 1998; Michishita et al., 2008) analyzing wide-ranging
interventions to change diabetes behaviors presented important data to support our study
concept.
and the recommendations from the 5 studies are similar, though diverse. Of course, individuals
with type 2 diabetes are prone to various cardiovascular risk factors such as dyslipidemia and
physically active lifestyles are recommended as they help in the effective control of blood sugar
levels and reduction of long-term complications of the disease. According to Albright et al.
(2000), exercise, coupled with medical nutrition therapy is recommended for the initial treatment
of T2D and lowering cardiovascular risk factors. Moderate weight loss has been found to aid
sufficient metabolic goals, and regular exercise and nutrition therapy combined are even more
effective in achieving quicker results unlike either alone of these strategies are used (Conn et al.,
2007). For instance, exercise is recommended as it results in the preferential upper body fat
CRITICAL APPRAISAL 9
mobilization. When exercise is combined with proper balanced diets, loss of visceral fats could
be the resultant benefit leading to the reduction of obesity and substantial improvement in
metabolic indices. In particular, abdominal obesity is deemed a major cardiovascular risk factor
and aids the development of T2D (Albright et al. 2000). Exercise is, thus, a valuable adjunct
modality along with changes in food intake when it comes to long-term management of weight.
Besides, patients who indulge in regular exercises can observe better nutritional advice as
physical activity enhances self-esteem and mood, and consequently contribute to improved
It is also stated that the psychosocial adjustments to T2D in later life may have significant
consequences on the patient’s perceived stress, psychological health (Albright et al., 2000) and
glucose control. Diabetic complications become more prevalent in individuals with long-
standing T2D and who require psychosocial adjustments (Estacio et al., 1998). Therefore, given
that the management of T2D is emotionally stressful, yet this stress can negatively affect
glycemic control, unlike clinical interventions, regular physical activities can be a vital step in
reducing stress while promoting psychological well-being and reducing cardiovascular risk
factors. The goal of T2D treatment is to achieve or maintain near-normal, if not normal blood
sugar levels (Michishita et al., 2008), but optimal lipid levels should also be achieved in order to
delay or prevent macrovascular and microvascular complications. Aside from improving insulin
sensitivity (Michishita et al., 2008), exercise, unlike many anti-diabetic medications, modifies
lipid abnormalities and changes hypertensive levels to prevent cardiovascular diseases (Albright
et al., 2000).
Nonetheless, exercise programs for adults with T2D and those without significant
resistance for ensuring cardiorespiratory fitness (Estacio et al., 1998), appropriate body
composition, muscular endurance and strength (Albright et al., 2000). For that matter, the
increasing fat-free weight (Castaneda et al., 2002). In addition, appropriate intensity, frequency,
modes and duration of the exercise program should be identified for adults with type 2 diabetes.
In order to improve cardiovascular outcomes and secure successful results among adults with
T2D, interventions designed to encourage exercise regimen adoption should be responsive to the
current state of readiness of the patient and focus efforts on helping the individual move through
the various levels of behavioral change. Probably, for most exercise interventions, continuous
monitoring and positive reinforcement are crucial, and this can be made possible through a
References
Albright, A., Franz, M., Hornsby, G., Kriska, A., Marrero, D., Ullrich, I., & Verity, L. S. (2000).
American College of Sports Medicine position stand. Exercise and type 2 diabetes.
Castaneda, C., Layne, J. E., Munoz-Orians, L., Gordon, P. L., Walsmith, J., Foldvari, M., ... &
improve glycemic control in older adults with type 2 diabetes. Diabetes care, 25(12),
2335-2341.
Conn, V. S., Hafdahl, A. R., Mehr, D. R., LeMaster, J. W., Brown, S. A., & Nielsen, P. J. (2007).
Estacio, R. O., Regensteiner, J. G., Wolfel, E. E., Jeffers, B., Dickenson, M., & Schrier, R. W.
(1998). The association between diabetic complications and exercise capacity in NIDDM
Michishita, R., Shono, N., Kasahara, T., & Tsuruta, T. (2008). Effects of low intensity exercise
therapy on early phase insulin secretion in overweight subjects with impaired glucose
tolerance and type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 82(3),
291-297.